Dechert Advises on SparingVision Series A2 Fundraising

Dechert advised 4Bio Capital and Ysios Capital, as investors, in connection with SparingVision’s €44.5 million Series A2 fundraising.

SparingVision is a biotechnology company specialized in the research and development of an innovative therapeutic approach for the treatment of inherited retinal degenerative diseases such as retinitis pigmentosa.

Dechert advised the investors on legal aspects with:

• in corporate: Anne-Charlotte Rivière, partner, with Aude Steinberg and Johann Gandilhon, associates;
• in intellectual property: Marie Fillon, national partner with Louis de Chezelles, associate;
• in labor: Thibault Meiers, national partner with Maëlle Chausse, associate.

Translate to French

About Dechert

Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.